Literature DB >> 25318618

The difficulty in considering modifiable pathology risk factors in children with IgA nephropathy: crescents and timing of renal biopsy.

Rosanna Coppo1, Jean-Claude Davin.   

Abstract

The need for an early diagnosis of primary IgA nephropathy (IgAN) is particularly felt in children since they have a long life expectancy. However, IgAN has a slowly progressive course and renal function can even remain unchanged for decades. The long-term predictive value of modifiable risk factors, such as proteinuria and proliferative/inflammatory lesion at renal biopsy, remains unknown. Interest has focused on crescents, which represent a clear risk factor for renal vasculitides. A number of rare cases of extracapillary IgAN involving >40 % of glomeruli have been reported, but in most cases of IgAN crescents involve <10 % of glomeruli. The long-term effect of small non-circumferential crescents detected by chance or without a clinical picture of progressive IgAN is still unknown. The Oxford study failed to find a predictive value of crescents in either children or adults, and these results were confirmed by the recent VALIGA study on 1,147 patients with IgAN (174 children). A recent study reports a correlation between the time elapsed from the diagnosis of urinary abnormalities and renal biopsy which suggests that crescents are associated with disease onset and then likely undergo a healing process into sclerotic lesions, which are commonly detected in biopsies performed years after onset. The authors of this study propose that primary IgAN may have similarities with Henoch-Schoenlein purpura nephritis, which presents with acute glomerular damage, mesangial proliferation, endocapillary leucocyte infiltration and crescent formations, and that these lesions can undergo resolution with sclerotic healing. This hypothesis is highly suggestive of the silent progression of several cases of IgAN without clear clinical changes, stressing once more the need for a combined clinical and pathological evaluation of children with IgAN that considers both the underlying pathogenetic event and its possible evolution.

Entities:  

Mesh:

Year:  2014        PMID: 25318618     DOI: 10.1007/s00467-014-2954-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  20 in total

1.  Biopsy timing and Oxford classification variables in childhood/adolescent IgA nephropathy.

Authors:  Yuko Shima; Koichi Nakanishi; Taketsugu Hama; Masashi Sato; Hironobu Mukaiyama; Hiroko Togawa; Ryojiro Tanaka; Hiroshi Kaito; Kandai Nozu; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2014-06-07       Impact factor: 3.714

2.  Validity of the Oxford classification of IgA nephropathy in children.

Authors:  Yuko Shima; Koichi Nakanishi; Taketsugu Hama; Hironobu Mukaiyama; Hiroko Togawa; Yuya Hashimura; Hiroshi Kaito; Mayumi Sako; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2011-12-02       Impact factor: 3.714

3.  Renal biopsy criterion in children with asymptomatic constant isolated proteinuria.

Authors:  Taketsugu Hama; Koichi Nakanishi; Yuko Shima; Hironobu Mukaiyama; Hiroko Togawa; Ryojiro Tanaka; Kiyoshi Hamahira; Hiroshi Kaito; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Nephrol Dial Transplant       Date:  2012-01-09       Impact factor: 5.992

4.  The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility.

Authors:  Ian S D Roberts; H Terence Cook; Stéphan Troyanov; Charles E Alpers; Alessandro Amore; Jonathan Barratt; Francois Berthoux; Stephen Bonsib; Jan A Bruijn; Daniel C Cattran; Rosanna Coppo; Vivette D'Agati; Giuseppe D'Amico; Steven Emancipator; Francesco Emma; John Feehally; Franco Ferrario; Fernando C Fervenza; Sandrine Florquin; Agnes Fogo; Colin C Geddes; Hermann-Josef Groene; Mark Haas; Andrew M Herzenberg; Prue A Hill; Ronald J Hogg; Stephen I Hsu; J Charles Jennette; Kensuke Joh; Bruce A Julian; Tetsuya Kawamura; Fernand M Lai; Lei-Shi Li; Philip K T Li; Zhi-Hong Liu; Bruce Mackinnon; Sergio Mezzano; F Paolo Schena; Yasuhiko Tomino; Patrick D Walker; Haiyan Wang; Jan J Weening; Nori Yoshikawa; Hong Zhang
Journal:  Kidney Int       Date:  2009-07-01       Impact factor: 10.612

5.  The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification.

Authors:  Daniel C Cattran; Rosanna Coppo; H Terence Cook; John Feehally; Ian S D Roberts; Stéphan Troyanov; Charles E Alpers; Alessandro Amore; Jonathan Barratt; Francois Berthoux; Stephen Bonsib; Jan A Bruijn; Vivette D'Agati; Giuseppe D'Amico; Steven Emancipator; Francesco Emma; Franco Ferrario; Fernando C Fervenza; Sandrine Florquin; Agnes Fogo; Colin C Geddes; Hermann-Josef Groene; Mark Haas; Andrew M Herzenberg; Prue A Hill; Ronald J Hogg; Stephen I Hsu; J Charles Jennette; Kensuke Joh; Bruce A Julian; Tetsuya Kawamura; Fernand M Lai; Chi Bon Leung; Lei-Shi Li; Philip K T Li; Zhi-Hong Liu; Bruce Mackinnon; Sergio Mezzano; F Paolo Schena; Yasuhiko Tomino; Patrick D Walker; Haiyan Wang; Jan J Weening; Nori Yoshikawa; Hong Zhang
Journal:  Kidney Int       Date:  2009-07-01       Impact factor: 10.612

6.  Macroscopic hematuria in mesangial IgA nephropathy: correlation with glomerular crescents and renal dysfunction.

Authors:  W M Bennett; P Kincaid-Smith
Journal:  Kidney Int       Date:  1983-02       Impact factor: 10.612

7.  Acute reversible renal failure with macroscopic haematuria in IgA nephropathy.

Authors:  C Delclaux; C Jacquot; P Callard; D Kleinknecht
Journal:  Nephrol Dial Transplant       Date:  1993       Impact factor: 5.992

8.  Prognostic significance of the glomerular changes in Henoch-Schoenlein nephritis.

Authors:  N Yoshikawa; R H White; A H Cameron
Journal:  Clin Nephrol       Date:  1981-11       Impact factor: 0.975

9.  Spontaneous remission in children with IgA nephropathy.

Authors:  Yuko Shima; Koichi Nakanishi; Taketsugu Hama; Hironobu Mukaiyama; Hiroko Togawa; Mayumi Sako; Hiroshi Kaito; Kandai Nozu; Ryojiro Tanaka; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2012-09-02       Impact factor: 3.714

Review 10.  Henoch-Schönlein purpura nephritis in children.

Authors:  Jean-Claude Davin; Rosanna Coppo
Journal:  Nat Rev Nephrol       Date:  2014-07-29       Impact factor: 28.314

View more
  7 in total

1.  IgA nephropathy: is a new approach beyond proteinuria necessary?

Authors:  Eduardo Gutiérrez
Journal:  Pediatr Nephrol       Date:  2019-02-18       Impact factor: 3.714

Review 2.  Clinical and histological risk factors for progression of IgA nephropathy: an update in children, young and adult patients.

Authors:  Rosanna Coppo
Journal:  J Nephrol       Date:  2016-11-04       Impact factor: 3.902

Review 3.  IgA vasculitis nephritis in children and adults: one or different entities?

Authors:  Licia Peruzzi; Rosanna Coppo
Journal:  Pediatr Nephrol       Date:  2020-11-20       Impact factor: 3.714

Review 4.  Crescents and IgA Nephropathy: A Delicate Marriage.

Authors:  Hernán Trimarchi; Mark Haas; Rosanna Coppo
Journal:  J Clin Med       Date:  2022-06-21       Impact factor: 4.964

5.  B cell-depleting therapy with rituximab or ofatumumab in immunoglobulin A nephropathy or vasculitis with nephritis.

Authors:  Sigrid Lundberg; Emelie Westergren; Jessica Smolander; Annette Bruchfeld
Journal:  Clin Kidney J       Date:  2016-12-13

6.  IgA vasculitis nephritis clinical course and kidney biopsy - national study in children.

Authors:  Małgorzata Mizerska-Wasiak; Agnieszka Turczyn; Karolina Cichoń-Kawa; Jadwiga Małdyk; Monika Miklaszewska; Dorota Drożdż; Beata Bieniaś; Przemysław Sikora; Magdalena Drożyńska-Duklas; Aleksandra Żurowska; Maria Szczepańska; Małgorzata Pańczyk-Tomaszewska
Journal:  Pediatr Rheumatol Online J       Date:  2021-10-07       Impact factor: 3.054

7.  Endotrophin, a collagen type VI-derived matrikine, reflects the degree of renal fibrosis in patients with IgA nephropathy and in patients with ANCA-associated vasculitis.

Authors:  Nadja Sparding; Federica Genovese; Daniel Guldager Kring Rasmussen; Morten Asser Karsdal; Michaela Neprasova; Dita Maixnerova; Veronika Satrapova; Doubravka Frausova; Mads Hornum; Lenka Bartonova; Eva Honsova; Marek Kollar; Helena Koprivova; Zdenka Hruskova; Vladimir Tesar
Journal:  Nephrol Dial Transplant       Date:  2022-05-25       Impact factor: 7.186

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.